TY - JOUR
T1 - Beliefs related to health care incentives
T2 - Comparison of substance use disorder treatment providers, medical treatment providers, and a public sample
AU - Kirby, Kimberly
AU - Dwyer, Matthew J.
AU - Burrows, Connor
AU - Fife, Dustin A.
AU - Bresani, Elena
AU - Tabit, Mary
AU - Raiff, Bethany R.
N1 - Funding Information:
This work was supported by the National Institute on Drug Abuse of the National Institutes of Health ( P50 DA027841 & R21 DA036818 ). Dr. Kirby conceptualized and designed the study, worked with Dr. Tabit to revise the original Provider Survey of Incentives, wrote large sections of the manuscript, and was primarily responsible for completing the manuscript. Mr. Dwyer developed the secondary purposes, provided a partial initial draft of the manuscript, summarized data, developed tables and figures, and reviewed and edited manuscript drafts. Mr. Burrows conducted statistical analyses, generated tables and figures, wrote parts of the results section, and reviewed and edited manuscript drafts. Dr. Fife provided statistical consultation and directed analyses. Ms. Bresani arranged and oversaw execution of the study and edited and wrote parts of the methods section. Dr. Tabit also conducted literature reviews on the use of health incentives for medical conditions and reviewed and edited drafts of the manuscript. Dr. Raiff edited the final manuscript and made substantive edits. All authors read and approved the final draft of the manuscript. The authors have no competing interests to declare.
Funding Information:
This work was supported by the National Institute on Drug Abuse of the National Institutes of Health (P50 DA027841 & R21 DA036818). Dr. Kirby conceptualized and designed the study, worked with Dr. Tabit to revise the original Provider Survey of Incentives, wrote large sections of the manuscript, and was primarily responsible for completing the manuscript. Mr. Dwyer developed the secondary purposes, provided a partial initial draft of the manuscript, summarized data, developed tables and figures, and reviewed and edited manuscript drafts. Mr. Burrows conducted statistical analyses, generated tables and figures, wrote parts of the results section, and reviewed and edited manuscript drafts. Dr. Fife provided statistical consultation and directed analyses. Ms. Bresani arranged and oversaw execution of the study and edited and wrote parts of the methods section. Dr. Tabit also conducted literature reviews on the use of health incentives for medical conditions and reviewed and edited drafts of the manuscript. Dr. Raiff edited the final manuscript and made substantive edits. All authors read and approved the final draft of the manuscript. The authors have no competing interests to declare.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/10
Y1 - 2021/10
N2 - This study surveyed substance use disorder (SUD) treatment providers, medical treatment providers, and a public sample about beliefs regarding health care incentives to explore differences among the groups and across health disorders for which research has demonstrated incentives improve outcomes. Six hundred participants (n = 200/group) completed the Provider Survey of Incentives. The study found between group differences for positive and negative beliefs. The public sample was highest on the positive beliefs subscale (M = 3.81), followed by SUD (M = 3.63) and medical treatment providers (M = 3.48; F(2, 597) = 20.09, p < .001). The medical treatment providers were highest on the negative beliefs subscale (M = 2.91), compared to the public sample (M = 2.77) and SUD treatment providers (M = 2.65; F(2, 597) = 7.521, p < .001). Endorsement of incentives to treat medical disorders was similar across the groups, with obesity the most endorsed disorder. In contrast, endorsement of incentives to treat SUDs differed across groups, except for smoking. The SUD treatment providers were almost twice as likely as the public sample (OR = 1.81, 95% CI = 1.27–2.59) and the public sample almost twice as likely as the medical treatment providers (OR = 1.74, 95% CI = 1.24–2.47) to endorse the use of incentives to treat more SUDs. Medical treatment providers were also the least likely to endorse incentives to treat both legal and illicit substance use. These findings suggest that incentive programs have good acceptability among SUD treatment providers and the public, but medical treatment providers are less accepting of incentive programs. This study provides evidence that incentive-based interventions are acceptable to the public and is the first to document specific objections that individuals disseminating incentive interventions will most likely face when introducing them in medical settings.
AB - This study surveyed substance use disorder (SUD) treatment providers, medical treatment providers, and a public sample about beliefs regarding health care incentives to explore differences among the groups and across health disorders for which research has demonstrated incentives improve outcomes. Six hundred participants (n = 200/group) completed the Provider Survey of Incentives. The study found between group differences for positive and negative beliefs. The public sample was highest on the positive beliefs subscale (M = 3.81), followed by SUD (M = 3.63) and medical treatment providers (M = 3.48; F(2, 597) = 20.09, p < .001). The medical treatment providers were highest on the negative beliefs subscale (M = 2.91), compared to the public sample (M = 2.77) and SUD treatment providers (M = 2.65; F(2, 597) = 7.521, p < .001). Endorsement of incentives to treat medical disorders was similar across the groups, with obesity the most endorsed disorder. In contrast, endorsement of incentives to treat SUDs differed across groups, except for smoking. The SUD treatment providers were almost twice as likely as the public sample (OR = 1.81, 95% CI = 1.27–2.59) and the public sample almost twice as likely as the medical treatment providers (OR = 1.74, 95% CI = 1.24–2.47) to endorse the use of incentives to treat more SUDs. Medical treatment providers were also the least likely to endorse incentives to treat both legal and illicit substance use. These findings suggest that incentive programs have good acceptability among SUD treatment providers and the public, but medical treatment providers are less accepting of incentive programs. This study provides evidence that incentive-based interventions are acceptable to the public and is the first to document specific objections that individuals disseminating incentive interventions will most likely face when introducing them in medical settings.
UR - http://www.scopus.com/inward/record.url?scp=85104278139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104278139&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2021.108383
DO - 10.1016/j.jsat.2021.108383
M3 - Article
C2 - 34080551
AN - SCOPUS:85104278139
SN - 0740-5472
VL - 129
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
M1 - 108383
ER -